Cargando…

Autophagy-related genes affect the survival of multiple myeloma patients depending on chromosomal abnormality

BACKGROUND: Targeting autophagy at gene level may be promising in multiple myeloma (MM) treatment depending on chromosomal abnormality (ABN) status. OBJECTIVES: We aimed to investigate the role of ABN on survival of MM patients and to identify prognosis related autophagy-related genes (ARGs) for pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ayna Duran, Gizem, Benderli Cihan, Yasemin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321186/ https://www.ncbi.nlm.nih.gov/pubmed/37551318 http://dx.doi.org/10.2478/abm-2022-0028

Ejemplares similares

Is Height of Prognostic Significance in Breast Cancer Cases?
por: Cihan, Yasemin Benderli
Publicado: (2017)

Ga-68-PSMA PET/CT ? or PET/MRI ?, Mp-MRI ? in diagnosis and radiotherapy planning in a patient with prostate cancer
por: Cihan, Yasemin Benderli
Publicado: (2020)

Re: The role of (68)Ga-PSMA-PET/CT in radiotherapy planning in prostate cancer
por: Cihan, Yasemin Benderli
Publicado: (2019)

Role of postmastectomy radiation therapy in breast cancer patients with T1–2 and 1–3 positive lymph nodes
por: Cihan, Yasemin Benderli, et al.
Publicado: (2016)

Multiple Myeloma Immunophenotype Related to Chromosomal Abnormalities Used in Risk Assessment
por: Radzevičius, Mantas, et al.
Publicado: (2022)

Chromosome 1q21 abnormalities in multiple myeloma
por: Schmidt, Timothy M., et al.
Publicado: (2021)

Recurrence of retroperitoneal localized perivascular epithelioid cell tumor two years after initial diagnosis: case report
por: Cihan, Yasemin Benderli, et al.
Publicado: (2018)

Conventional Karyotyping and Fluorescence In Situ Hybridization for Detection of Chromosomal Abnormalities in Multiple Myeloma
por: Crabtree, Matthew, et al.
Publicado: (2022)

Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma
por: Binder, M, et al.
Publicado: (2017)

In multiple myeloma, bone-marrow lymphocytes harboring the same chromosomal abnormalities as autologous plasma cells predict poor survival
por: Marun, Carina S Debes, et al.
Publicado: (2012)

A predicted risk score based on the expression of 16 autophagy-related genes for multiple myeloma survival
por: Zhu, Fang-Xiao, et al.
Publicado: (2019)

Evaluation of chromosomal abnormalities by clg-FISH and association with proliferative and apoptotic indexes in multiple myeloma
por: Linardi, C.C.G., et al.
Publicado: (2012)

Development and validation of prognostic implications of chromosome abnormalities algorithm for newly diagnosed multiple myeloma
por: Luo, Tiancheng, et al.
Publicado: (2020)

Amp(1q) and tetraploidy are commonly acquired chromosomal abnormalities in relapsed multiple myeloma
por: Locher, Maurus, et al.
Publicado: (2022)

Retrospective analysis of genetic abnormalities and survival in 131 patients with multiple myeloma
por: LIU, NIAN, et al.
Publicado: (2015)

Abnormalities in Chromosomes 1q and 13 Independently Correlate With Factors of Poor Prognosis in Multiple Myeloma
por: Kim, Miyoung, et al.
Publicado: (2016)

Whole-genome optical mapping of bone-marrow myeloma cells reveals association of extramedullary multiple myeloma with chromosome 1 abnormalities
por: Kriegova, Eva, et al.
Publicado: (2021)

Hemostatic Abnormalities in Multiple Myeloma Patients
por: Gogia, Aarti, et al.
Publicado: (2018)

Systemic multiple myeloma and colonic abnormalities
por: Pawlak, Katarzyna M., et al.
Publicado: (2023)

Genetic Abnormalities in Extramedullary Multiple Myeloma
por: McAvera, Roisin, et al.
Publicado: (2023)

Characteristics and prognostic value of extramedullary chromosomal abnormalities in extramedullary myeloma
por: Xia, Yuan, et al.
Publicado: (2022)

Time-dependent endpoints as predictors of overall survival in multiple myeloma
por: Félix, Jorge, et al.
Publicado: (2013)

Bortezomib Treatment Modulates Autophagy in Multiple Myeloma
por: Di Lernia, Giuseppe, et al.
Publicado: (2020)

Hyperdiploid Multiple Myeloma with Novel Complex Structural Chromosome Abnormalities Associated with Poor Prognosis : A Rare Case Report
por: Ankathil, Ravindran, et al.
Publicado: (2021)

RNA sequencing identifies novel regulated IRE1-dependent decay targets that affect multiple myeloma survival and proliferation
por: Quwaider, Dalia, et al.
Publicado: (2022)

Genetic Abnormalities in Multiple Myeloma: Prognostic and Therapeutic Implications
por: Cardona-Benavides, Ignacio J., et al.
Publicado: (2021)

Autophagy regulates the survival of cells with chromosomal instability
por: Liu, Dawei, et al.
Publicado: (2016)

Chromosomal instability and acquired drug resistance in multiple myeloma
por: Wang, Wang, et al.
Publicado: (2017)

Co-Chaperone Bag-1 Plays a Role in the Autophagy-Dependent Cell Survival through Beclin 1 Interaction
por: Turk, Miray, et al.
Publicado: (2021)

Amplification of Chromosome 1q Predicts Poor Overall Survival in Newly Diagnosed Multiple Myeloma Patients
por: Skerget, Matevz, et al.
Publicado: (2023)

Alpha Particles Induce Autophagy in Multiple Myeloma Cells
por: Gorin, Jean-Baptiste, et al.
Publicado: (2015)

P26 LANDSCAPE OF RECURRENT CYTOGENETIC ABNORMALITIES IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA AS DETECTED BY CHROMOSOME MICROARRAY ANALYSIS (CMA)
por: Varshavsky Yanovsky, A., et al.
Publicado: (2023)

Long-term survival in multiple myeloma
por: João, Cristina, et al.
Publicado: (2014)

p53 Abnormalities and Potential Therapeutic Targeting in Multiple Myeloma
por: Teoh, P. J., et al.
Publicado: (2014)

Relationship between abnormal osteoblasts and cellular immunity in multiple myeloma
por: Fu, Rong, et al.
Publicado: (2014)

An Abnormal Presentation of Multiple Myeloma in Pregnancy: A Case Report
por: Chory, Robert M, et al.
Publicado: (2022)

B03: SKELETAL-RELATED EVENTS AND ABNORMAL MRI PATTERN AT DIAGNOSIS ARE ASSOCIATED WITH INFERIOR OVERALL SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
por: Terpos, Evangelos, et al.
Publicado: (2022)

Inhibition of autophagy enhances the antitumour activity of tigecycline in multiple myeloma
por: Ma, Ruye, et al.
Publicado: (2018)

The Role of Chaperone-Mediated Autophagy in Bortezomib Resistant Multiple Myeloma
por: Nikesitch, Nicholas, et al.
Publicado: (2021)

GFI1-Dependent Repression of SGPP1 Increases Multiple Myeloma Cell Survival
por: Petrusca, Daniela N., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0qidm7tf4p2qvjqhvb2689fttl